Australia Perfusion Systems Market Size & Outlook, 2023-2030
- MedTech
- General Surgery
- Perfusion Systems Market Outlook
- General Surgery
Australia Perfusion Systems Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the perfusion systems market
Australia perfusion systems market highlights
- The Australia perfusion systems market generated a revenue of USD 29.5 million in 2023 and is expected to reach USD 42.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 5.4% from 2024 to 2030.
- In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
- Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
Perfusion systems market data book summary
| Market revenue in 2023 | USD 29.5 million |
| Market revenue in 2030 | USD 42.7 million |
| Growth rate | 5.4% (CAGR from 2023 to 2030) |
| Largest segment | Cardiopulmonary perfusion system |
| Fastest growing segment | Cardiopulmonary Perfusion System |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
| Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
Other key industry trends
- In terms of revenue, Australia accounted for 2.6% of the global perfusion systems market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan perfusion systems market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 20.0 million by 2030.
The rising prevalence of chronic respiratory diseases is a significant driver of the perfusion system market in Australia. According to the Australian Bureau of Statistics, the prevalence of COPD has been stable, increasing slightly from 2.4% in 2011 to 2012 to 2.5% in 2022.
More patients are seeking treatment for respiratory failure, increasing the demand for effective perfusion systems. These systems are also crucial for expediting recovery during heart and lung surgeries. In addition, their growing popularity is due to reduced patient trauma, shorter hospital stays, and quicker recovery time.
These factors are expected to enhance the adoption of perfusion systems in Australia’s healthcare sector. According to the Australian Institute of Health and Welfare, in 2023, respiratory conditions accounted for 7.2% of the total disease burden (measured in Disability-adjusted Life Years or DALYs), 8.5% of the nonfatal burden (Years Lived With Disability or YLDs), and 5.8% of the fatal burden (Years of Life Lost or YLLs) in Australia.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Perfusion Systems Market Scope
Perfusion Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Getinge AB ADR | View profile | 11,862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | www.getinge.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Spectrum Brands Holdings Inc | View profile | 3,100 | 3001 Deming Way, Middleton, WI, United States, 53562 | www.spectrumbrands.com |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| LivaNova PLC | View profile | 2,900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | www.livanova.com |
| Repligen Corp | View profile | 1,783 | 41 Seyon Street, Building 1, Suite 100, Waltham, MA, United States, 02453 | www.repligen.com |
| Fresenius Medical Care AG | View profile | 119,845 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | www.freseniusmedicalcare.com |
| Xvivo Perfusion AB | View profile | 130 | Gemenskapens gata 9, Mölndal, Sweden, SE-431 53 | www.xvivoperfusion.com |
Australia Perfusion Systems Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Perfusion Systems Market Outlook will help companies and investors design strategic landscapes.
Cardiopulmonary Perfusion System was the largest segment with a revenue share of 44.75% in 2023.
Horizon Databook has segmented the Australia perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of chronic respiratory diseases is a significant driver of the perfusion system market in Australia. According to the Australian Bureau of Statistics, the prevalence of COPD has been stable, increasing slightly from 2.4% in 2011 to 2012 to 2.5% in 2022.
More patients are seeking treatment for respiratory failure, increasing the demand for effective perfusion systems. These systems are also crucial for expediting recovery during heart and lung surgeries. In addition, their growing popularity is due to reduced patient trauma, shorter hospital stays, and quicker recovery time.
These factors are expected to enhance the adoption of perfusion systems in Australia’s healthcare sector. According to the Australian Institute of Health and Welfare, in 2023, respiratory conditions accounted for 7.2% of the total disease burden (measured in Disability-adjusted Life Years or DALYs), 8.5% of the nonfatal burden (Years Lived With Disability or YLDs), and 5.8% of the fatal burden (Years of Life Lost or YLLs) in Australia.
- Australia Perfusion Systems Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cardiopulmonary Perfusion System
- Cell Perfusion System
- Ex-Vivo Organ Perfusion System
Reasons to subscribe to Perfusion Systems Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Perfusion Systems Market Outlook databook
- Our clientele includes a mix of Perfusion Systems Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Perfusion Systems Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Perfusion Systems Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia Perfusion Systems Market, 2018-2030 (US$M)
Australia perfusion systems market statistics, by application, 2018-2030 (US$M)
